Enzyre
Enzyre is a developer of diagnostic technology.
Enzyre has raised €13M across 2 funding rounds from 7 investors, most recently a Series A round in Nov 2022. Based in Nijmegen, Netherlands; founded 2016; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€13M
€13,400,000
Funding rounds
2
Investors
7
distinct backers
Active since
2020-07
latest 2022-11
Funding by year
EUR raised per yearEnzyre — funding by year — interactive chart.
Data table
| Enzyre — funding by year | |
|---|---|
| 2020 | €1.4M |
| 2022 | €12M |
Signals
High confidenceRaise-next likelihood9
base rate 44% for Series A
- ▼ Past typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood8
base rate 11% (2+ rounds)
- ▲ 10y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-11-02 | Series A | €12M | Demcon Investment,Dutch Government,i&i Biotech Fund,Novalis Biotech,Oost NL,Takeda Ventures | View deal → |
| 2020-07-27 | Other | €1.4M | Novalis Biotechnology Incubation | View deal → |
Investors
7Related news
- Dutch startup Enzyre snaps €12M for empowering haemophilia patients to optimise treatment themselvestechfundingnews.com · 2022-11
- finsmes.com
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Picnic€1.7BNetherlands · E-commerce
- Just Eat Takeaway€1.6BNetherlands · Foodtech
- Nebius€1.5BNetherlands · Cloud
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData